Carneiro, B. A., Papadopoulos, K. P., Strickler, J. H., Lassman, A. B., Waqar, S. N., Chae, Y. K., Patel, J. D., Shacham-Shmueli, E., Kelly, K., Khasraw, M., Bestvina, C. M., Merrell, R., Huang, K., Atluri, H., Ansell, P., Li, R., Jin, J., Anderson, M. G., Reilly, E. B., Morrison-Thiele, G., Patel, K., Robinson, R. R., Aristide, M. R. N., & Gan, H. K. (2023). phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced glioblastoma. Neuro-oncology advances, 5(1), . http://access.bl.uk/ark:/81055/vdc_100179398590.0x000005